XML 29 R15.htm IDEA: XBRL DOCUMENT
v3.20.4

GOODWILL AND INTANGIBLE ASSETS | 12 Months Ended
--- | ---
Dec. 26, 2020
Goodwill and Intangible Assets Disclosure [Abstract] |
GOODWILL AND INTANGIBLE ASSETS | GOODWILL AND INTANGIBLE ASSETS Goodwill The following table provides a rollforward of the Company’s goodwill:
|  |  | Adjustments to Goodwill |  |  |  | Adjustments to Goodwill |  |
| December 29, 2018 |  | Acquisitions |  | Foreign Exchange |  | December 28, 2019 |  | Acquisitions |  | Foreign Exchange |  | December 26, 2020
| (in thousands)
RMS | $ | 56,968 |  |  | $ | — |  |  | $ | (382) |  |  | $ | 56,586 |  |  | $ | 229,654 |  |  | $ | 1,519 |  |  | $ | 287,759 |
DSA | 2,056,470 |  |  | 293,380 |  |  | 373 |  |  | 2,350,223 |  |  | (629) |  |  | 33,536 |  |  | 2,383,130 |
Manufacturing | 138,695 |  |  | — |  |  | 61 |  |  | 138,756 |  |  | — |  |  | 4,523 |  |  | 143,279 |
Gross carrying amount | 2,252,133 |  |  | 293,380 |  |  | 52 |  |  | 2,545,565 |  |  | 229,025 |  |  | 39,578 |  |  | 2,814,168 |
Accumulated impairment loss - DSA | (1,005,000) |  |  | — |  |  | — |  |  | (1,005,000) |  |  | — |  |  | — |  |  | (1,005,000) |
Goodwill | $ | 1,247,133 |  |  |  |  |  |  | $ | 1,540,565 |  |  |  |  |  |  | $ | 1,809,168 |
Based on the Company’s quantitative goodwill impairment test, which was performed in the fourth quarter for each of the fiscal years 2020, 2019 and 2018, the fair value of each reporting unit exceeded the reporting unit’s book value and, therefore, goodwill was not impaired. The increase in goodwill during fiscal year 2020 related primarily to the acquisitions of HemaCare and Cellero in the RMS reportable segment. The increase in goodwill during fiscal year 2019 related primarily to the acquisition of Citoxlab in the DSA reportable segment. Intangible Assets, Net The following table displays intangible assets, net by major class:
| December 26, 2020 |  | December 28, 2019
| Gross |  | Accumulated Amortization |  | Net |  | Gross |  | Accumulated Amortization |  | Net
| (in thousands)
Backlog | $ | 29,233 |  |  | $ | (29,233) |  |  | $ | — |  |  | $ | 28,865 |  |  | $ | (26,895) |  |  | $ | 1,970 |
Technology | 130,907 |  |  | (81,305) |  |  | 49,602 |  |  | 122,106 |  |  | (57,737) |  |  | 64,369 |
Trademarks and trade names | 15,870 |  |  | (5,648) |  |  | 10,222 |  |  | 8,430 |  |  | (4,901) |  |  | 3,529 |
Other | 20,903 |  |  | (14,633) |  |  | 6,270 |  |  | 18,279 |  |  | (12,307) |  |  | 5,972 |
Other intangible assets | 196,913 |  |  | (130,819) |  |  | 66,094 |  |  | 177,680 |  |  | (101,840) |  |  | 75,840 |
Client relationships | 1,137,331 |  |  | (415,826) |  |  | 721,505 |  |  | 934,668 |  |  | (321,095) |  |  | 613,573 |
Intangible assets | $ | 1,334,244 |  |  | $ | (546,645) |  |  | $ | 787,599 |  |  | $ | 1,112,348 |  |  | $ | (422,935) |  |  | $ | 689,413 |
The increase in intangible assets, net during fiscal year 2020 related primarily to the acquisitions of HemaCare and Cellero. Amortization expense of definite-lived intangible assets, including client relationships, for fiscal years 2020, 2019 and 2018 was $111.9 million, $89.5 million and $64.8 million, respectively. As of December 26, 2020, estimated amortization expense for intangible assets for each of the next five fiscal years is expected to be as follows:
Fiscal Year |  | Amortization Expense
|  | (in thousands)
2021 |  | $ | 104,272 |
2022 |  | 91,877 |
2023 |  | 83,651 |
2024 |  | 76,291 |
2025 |  | 71,915 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration